Țară: Israel
Limbă: engleză
Sursă: Ministry of Health
FLORFENICOL; FLUNIXIN MEGLUMINE
INTERVET ( ISRAEL) LTD
SOLUTION FOR INJECTION
FLORFENICOL 300 MG/ML; FLUNIXIN MEGLUMINE 27.4 MG/ML
S.C
Required
VET PHARMA FRIESOYTHE GMBH, GERMANY
Therapeutic treatment of febrile respiratory tract infections caused by Mannheimia haemolytica , Pasteurella multocida , Mycoplasma bovis or histophilus somni in cattle.
2016-06-30
PATIENT PACKAGE INSERT FOR A VETERINARY PRODUCT The medicine is only dispensed with a veterinarian’s prescription For veterinary use only 1. NAME OF THE VETERINARY MEDICINAL PRODUCT, ITS DOSAGE FORM AND CONCENTRATION RESFLOR VETERINARY SOLUTION FOR INJECTION FOR CATTLE 2. ACTIVE INGREDIENT(S) Each 1 ml of solution contains the active ingredients: Florfenicol 300 mg Flunixin meglumine 27.4 mg (equivalent to 16.5 mg of free flunixin) 3 . WHAT IS THE MEDICINE INTENDED FOR Treatment of respiratory infections in cattle caused by _ _ _Mannheimia haemolytica_, _Pasteurella multocida, Mycoplasma bovis,_ _Histophilus somni_ accompanied by fever. THERAPEUTIC GROUP: FLORFENICOL IS A BROAD SPECTRUM ANTIBIOTIC FLUNIXIN MEGLUMINE IS A NON-STEROIDAL ANTI-INFLAMMATORY AGENT 4 . CONTRAINDICATIONS Do not use in adult bulls intended for breeding purposes. Do not use in animals suffering from hepatic and renal diseases. Do not use if there is a risk of gastrointestinal bleeding. And do not use in cases where there is evidence of altered hemostasis. Do not use in animals known to be hypersensitive to one of the ingredients of the medicine. Do not use in animals suffering from cardiac diseases. 5. ADVERSE REACTIONS Subcutaneous administration of the product may result in injection site swellings that become palpable 2-3 days after injection. This swelling may last from 15 to 36 days following the injection. This reaction may be associated with minimal to mild irritation of the subcutis. Extension into the underlying muscle has been noted in only a few instances. After 56 days, no skin effects were observed that would require any trim-out at slaughter. Side effects can be reported to the Ministry of Health by clicking on the link “Report Side Effects of Drug Treatment” found on the Ministry of Health homepage (www.health.gov.il) that directs you to the online form for reporting side effects, or by entering the link: https://sideeffects.health.gov.il/ 6. TARGET SPECIES Cattle 7. METHOD OF ADMINISTRATION AND DOSAGE Only by subcutan Citiți documentul complet
Page 1 of 6 _This leaflet format has been determined by the Ministry of Health and the content has been checked and _ _approved on May 2019_ SUMMARY OF PRODUCT CHARACTERISTCS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Resflor Veterinary 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each mL contains Active substance: Florfenicol 300.0 mg Flunixin meglumine 27.4 mg (equivalent to 16.5 mg of free flunixin) Excipients: Propylene glycol (Antimicrobial Preservative) 150.0 mg For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for injection Clear, light yellow to straw coloured liquid 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Therapeutic treatment of febrile respiratory tract infections caused by Mannheimia haemolytica, Pasteurella multocida, Mycoplasma bovis or histophilus somni in cattle. 4.3 CONTRA-INDICATIONS Do not use in adult bulls intended for breeding purposes. Do not use in animals suffering from hepatic and renal diseases. Do not use if there is a risk of gastrointestinal bleeding or in cases where there is evidence of altered hemostasis. Do not use in animals suffering from cardiac diseases. Do not use in the case of known hypersensitivity to active substances or to any of the excipients listed in section 6.1. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE Page 2 of 6 (i) Special precautions for use in animals Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria. Official and local antimicrobial policies should be taken into account when the product is used. Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to florfenicol. Avoid use in dehydrated, hypovolaemic or hypotensive animals as there is a potential risk of incre Citiți documentul complet